FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

34697311000001103: Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Aug 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2880171000001114 Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2880181000001111 Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet Is a Ethinylestradiol 30microgram / Drospirenone 3mg tablets 21 tablet true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet Has AMP Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet Has specific active ingredient Drospirenone true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start